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ABSTRACT
Rationale Acute respiratory distress syndrome (ARDS)
affects over 200 000 people annually in the USA.
Despite causing severe, and often refractory,
hypoxaemia, the high mortality and long-term morbidity
of ARDS results mainly from extra-pulmonary organ
failure; however the mechanism for this organ crosstalk
has not been determined.
Methods Using autologous radiolabelled neutrophils
we investigated the pulmonary transit of primed and
unprimed neutrophils in humans. Flow cytometry of
whole blood samples was used to assess transpulmonary
neutrophil priming gradients in patients with ARDS,
sepsis and perioperative controls.
Main results Unprimed neutrophils passed through
the lungs with a transit time of 14.2 s, only 2.3 s slower
than erythrocytes, and with <5% ﬁrst-pass retention.
Over 97% of neutrophils primed ex vivo with
granulocyte macrophage colony-stimulating factor were
retained on ﬁrst pass, with 48% still remaining in the
lungs at 40 min. Neutrophils exposed to platelet-
activating factor were initially retained but subsequently
released such that only 14% remained in the lungs at
40 min. Signiﬁcant transpulmonary gradients of
neutrophil CD62L cell surface expression were observed
in ARDS compared with perioperative controls and
patients with sepsis.
Conclusions We demonstrated minimal delay and
retention of unprimed neutrophils transiting the healthy
human pulmonary vasculature, but marked retention of
primed neutrophils; these latter cells then ‘deprime’ and
are re-released into the systemic circulation. Further, we
show that this physiological depriming mechanism may
fail in patients with ARDS, resulting in increased
numbers of primed neutrophils within the systemic
circulation. This identiﬁes a potential mechanism for the
remote organ damage observed in patients with ARDS.
INTRODUCTION
Acute respiratory distress syndrome (ARDS) affects
200 000 people each year in the USA, and has a
mortality rate of approximately 40%.1 Due to
alterations in demographic factors, it has been esti-
mated that the incidence of ARDS will climb to
335 000 cases per annum by 2030.2 Despite
causing severe hypoxaemic respiratory failure, most
patients with ARDS die as a consequence of non-
pulmonary organ failure.1 Recently it has been
established that even survivors of ARDS have sig-
niﬁcant long-term extra-pulmonary organ dysfunc-
tion.3 4 The clinical observation that patients with
hypoxemic respiratory failure acquire signiﬁcant
remote organ dysfunction has led to interest in the
concept of organ ‘crosstalk’.
Several experimental and clinical studies provide
evidence to support the concept that lung damage
may propagate to remote organs. However, the
mechanisms by which this happens are not yet
established. Imai and colleagues5 demonstrated that
injurious mechanical ventilation may lead to epithe-
lial cell apoptosis in remote organs such as the
kidney, which they propose is induced by factors
released by the lung. Similarly, Guery et al6
reported elevated plasma tumour necrosis factor
α levels and gut permeability in a ventilator-
induced lung injury model, supporting the hypoth-
esis of crosstalk between the lungs and the gastro-
intestinal tract. There is also similar evidence for
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Key messages
What is the key question?
▸ How does acute respiratory distress syndrome
(ARDS) result in extra-pulmonary organ failure?
What is the bottom line?
▸ The healthy human lung may play a critical role
in host defence by selectively retaining primed
neutrophils, facilitating their depriming and
re-releasing them into the systemic circulation
in a quiescent state; this depriming mechanism
appears to fail in patients with ARDS, resulting
in exposure of remote organs to primed
neutrophils.
Why read on?
▸ We demonstrate for the ﬁrst time that the
healthy human lung can retain primed
neutrophils, facilitate their depriming and later
re-release them into the systemic circulation,
and that in patients with ARDS this depriming
mechanism appears to fail, resulting in
elevated levels of primed neutrophils within the
systemic circulation. This provides a potent
mechanism for the extra-pulmonary organ
damage occurring in ARDS.
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lung–brain interaction.7 While humeral factors have been sug-
gested to mediate such interactions, cellular mechanisms may
also operate.
Neutrophils are the most abundant circulating white cells in
man, and are key effectors of the innate immune response. In
contrast, inappropriate accumulation, or activation, of these cells,
and/or their delayed clearance, has been linked to several disease
states, including ARDS.8 The extreme histotoxic potential of
neutrophils dictates the need for safety mechanisms to prevent
their inadvertent activation. One such mechanism is priming.
Neutrophil priming refers to the process whereby exposure of
these cells to a variety of inﬂammatory mediators or physico-
chemical perturbations increases subsequent agonist-induced
responses. Priming has direct effects on respiratory burst
generation, neutrophil shape, deformability, integrin expressio,
and longevity, and as a consequence has a profound impact
on the rheological, adhesive and survival properties of these
cells.9 Most importantly, priming has been shown to be a
prerequisite for neutrophil-mediated tissue injury; indeed the
recruitment of large numbers of primed ‘hyper-responsive’
neutrophils to the lung is thought to play a critical role in the
genesis of ARDS.10 11
We provide evidence that the healthy pulmonary vasculature
may play an important role in host defence by selectively retain-
ing circulating primed neutrophils, facilitating their ‘depriming’,
and later releasing them back into the systemic circulation in a
quiescent state. We also demonstrate that this depriming mech-
anism appears to fail in patients with ARDS, leading to elevated
levels of primed neutrophils in the systemic circulation, thus
providing a potent mechanism for remote organ damage.
MATERIALS AND METHODS
Two independent methods were used to examine the transit of
radiolabelled autologous neutrophils across the lungs of human
subjects. All subjects had normal spirometry, no pulmonary
symptoms and were non-smokers. Informed consent was
obtained in all cases, and the Cambridge and Hertfordshire
Research Ethics Committees approved the study protocols
(08/H0306/17; 03/385; 08/H0311/62).
Neutrophil isolation and radiolabelling
Neutrophils were puriﬁed from peripheral venous blood using
lipopolysaccharide-free discontinuous plasma-Percoll gradients
and radiolabelled with either 111indium tropolonate or
99mtechnetium-HMPAO, in the presence of autologous plasma,
as described previously.12 13 Autologous erythrocytes were puri-
ﬁed and labelled with 99mtechnetium (as pertechnetate). All cells
were resuspended in 100% autologous plasma for reinjection.
Ex vivo priming of neutrophils
Neutrophils, isolated and radiolabelled as above, were resus-
pended in autologous plasma and stimulated at 37°C with
granulocyte macrophage colony-stimulating factor (GM-CSF)
(100 ng/mL) or platelet-activating factor (PAF) (1 μM) for 5 min
(PAF-primed neutrophils) or 30 min (deprimed neutrophils). The
cells were then washed with autologous plasma (150 g, 5 min at
room temperature) and resuspended in plasma.
Measurement of neutrophil transit time using γ scintigraphy
99mTechnetium-labelled neutrophils were injected into a left
antecubital fossa vein of spontaneously breathing adults in the
supine position. Imaging was performed using an Elscint
double-headed γ camera ﬁtted with medium energy collimators.
To assess the pulmonary transit of neutrophils, a dynamic
sequence was acquired at a frame rate of 1/s for 2 min, followed
by 1 frame/20 s for a further 38 min. Representative images
from the posterior head of the γ camera, acquired 40 min after
injection, are shown in ﬁgure 1. Regions of interest (ROIs) were
drawn around the right ventricle and lungs, and the mean
counts per pixel recorded. A γ variate was ﬁtted using a least
squares residual method to simulate the ﬁrst pass time–concen-
tration curve for neutrophils across the lung. This experiment
was undertaken using unprimed neutrophils (n=8), GM-CSF
primed neutrophils (n=8), PAF primed neutrophils (n=5) and
PAF deprimed neutrophils (n=6). The demographics of the sub-
jects participating are shown in table 1.
Measurement of neutrophil transit time using outﬂow tract
sampling
111Indium-tropolonate-labelled neutrophils and 99mtechnetium-
labelled erythrocytes were mixed and reinjected as a single bolus
into the right internal jugular vein of six anaesthetised adults
(table 2), prior to remote surgery. Using a high ﬁdelity peristaltic
pump (LiDCO, UK) and fraction counter (Pharmacia LKB
FRAC-100), blood samples were taken every 3.6 s for 4 min
from a left radial arterial catheter. Blood 111indium and 99miech-
netium concentrations were measured in the collected fractions
using a Wallac Wizard 3–1480 Automatic Gamma Counter.
Samples were recounted after 10 99mtechnetium half lives had
elapsed (t1/2=6.02 h) to ensure accuracy of the indium counting
(t1/2
111In=67.4 h). Measured activity values were corrected for
background radiation, radioisotope decay and crosstalk, before
being expressed as a fraction of the injected activity. To remove
the effects of cell recirculation and to simulate a ﬁrst-pass transit
curve, the time–concentration curves were ﬁtted with γ variate
functions using a least squares residual method. Mean transit
times for neutrophils and erythrocytes were derived from the
areas under the ﬁrst-pass transit curves.
The pulmonary retention fraction of neutrophils was calcu-
lated using the methodology of Hogg et al.14
Retention fraction ¼ 1 Area under curve ðneutrophilÞ
Area under curve ðerythrocyteÞ
Assessment of neutrophil priming gradients
Paired samples of whole blood were simultaneously obtained
from the radial artery and internal jugular veins of critically ill
patients with systemic sepsis with no evidence of pulmonary
involvement (n=6), ARDS (diagnosed according to The ARDS
Deﬁnition Task Force15; n=8), and perioperative control
patients (n=5) (table 3). Absolute neutrophil count was mea-
sured using a Coulter DXH automated counter, whilst neutro-
phil shape change, CD11b and CD62L cell surface expression
were analysed using a no-lysis whole blood ﬂow cytometry
method, based on a previous publication.16 Gradients were
expressed as a ratio of the arterial value over the venous value.
The raw data are provided in online supplementary table S1.
Statistical analysis
Because of small sample sizes, and because the normality of dis-
tribution of the data could neither be assumed nor tested, non-
parametric methods were used for statistical analysis. A p value
of <0.05 was considered signiﬁcant. Data are expressed as
median (IQR) unless otherwise speciﬁed.
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RESULTS
Less than 5% of unprimed neutrophils are retained by the
healthy pulmonary vasculature
Gamma scintigraphy of 111indium-labelled neutrophils, pre-
pared in the continuous presence of autologous plasma, rein-
jected into healthy volunteers demonstrated that the transit time
of unprimed neutrophils across the pulmonary circulation was
14.2 s (14.1–14.6 s) (n=8; ﬁgure 2A). All lung washout curves
were mono-exponential, and following ﬁrst pass there was no
detectable accumulation of neutrophils within the lungs over the
subsequent 40 min (data not shown).
Given that the transit time of unprimed neutrophils in our
experiments was signiﬁcantly faster than values reported in the
literature, we undertook additional validation of our ﬁndings,
using a second approach involving a novel outﬂow-tract sam-
pling method. In these experiments the transit time of unprimed
neutrophils from the right internal jugular vein to the left radial
artery was found to be only 2.3 s (0.9–4.2 s) longer than that
of admixed 99mtechnetium-labelled erythrocytes, and less than
5% of the injected neutrophils were retained in the lungs on
ﬁrst pass (4.7% (0.5–9.2%); n=6; ﬁgure 2B). The washout
curve of neutrophils from the lung was again mono-exponential,
suggesting that the vast majority of neutrophils traversed the
pulmonary vasculature with only minimal delay. Additional
data, obtained in a further four subjects who were given radiola-
belled ‘mixed leukocytes’ that had not been exposed to the
Percoll-plasma isolation procedure, revealed a mixed leukocyte
delay, compared with simultaneous erythrocyte transit, of 3.1 s
(2.1–4.9 s), supporting the view that there were no detrimental
effects of the neutrophil isolation technique used.
Neutrophil priming causes reversible retention of
neutrophils by the pulmonary vasculature
Remarkably, 96.5% (96.0–98.7%) of autologous radiolabelled
neutrophils primed ex vivo with GM-CSF (n=8) were retained
on ﬁrst pass across the lung, with no evidence of washout over
the ﬁrst 2 min. Subsequently, these neutrophils were released
slowly from the pulmonary vascular bed, such that 48.3%
(42.5–59.7%) of the maximal 99mtechnetium signal detected
within the lung ROI was still present 40 min post injection. A
total of 12.9% (11.2–17.4%) of the injected GM-CSF primed
neutrophils were recovered from the peripheral blood 40 min
post injection.
We have shown previously in vitro that, in contrast to
GM-CSF, PAF can induce neutrophil priming that is fully revers-
ible, with maximal priming effect at 5 min and a recovery to an
unprimed state by 30 min.17 Neutrophils exposed to PAF ex
vivo for 5 min and reinjected into healthy volunteers were ini-
tially retained in the lungs, as observed with GM-CSF primed
cells, but were subsequently released far more rapidly, such that
only 13.9% (13.3–14.3%) of the maximal signal was still
observed at 40 min (n=5). This would ﬁt predictions based on
previously published in vitro observations regarding the differ-
ent time courses of priming responses elicited by different ago-
nists.18 Neutrophils exposed to PAF for 30 min (by which time
we would predict they would be fully ‘deprimed’) appeared
Figure 1 Representative images obtained from the posterior head of γ camera 40 min after injection of autologous human neutrophils.
Autologous 99mtechnetium (Tc)-labelled neutrophils were primed with granulocyte macrophage colony-stimulating factor (GM-CSF) (100 ng/mL,
30 min, n=8), platelet-activating factor (PAF) (1 μM, 5 min, n=5; or 30 min, n=6), or control (phosphate-buffered saline (PBS), 5 min, n=8), washed
twice with autologous plasma (150 g, 5 min) and resuspended in plasma, before being reinjected into the left antecubital fossa of healthy
spontaneously breathing volunteers, lying supine in a dual-headed γ camera. Images were acquired at 1/s for 2 min, followed by 1/20 s for 38 min,
from the time of injection. (A–C) Shows representative images from the posterior head of the γ camera for unprimed (A), deprimed (PAF for 30 min;
B) and GM-CSF primed (C) autologous neutrophils 40 min post injection into the left antecubital fossa. 111In, 111indium tropolonate; RBC, red blood
cell; ROI, region of interest.
Table 1 Demographics of subjects undergoing gamma scintigraphy
All Control GM-CSF PAF primed PAF deprimed
N 27 8 8 5 6
Number of men 9 2 4 1 2
Age in years 50.5 (46.8–59.3) 50.0 (47.0–62.8) 52.5 (45.2–61.0) 50.0 (49.0–55.5) 55.0 (45.5–56.5)
Percentage predicted FEV1/FVC 78.1 (72.5–82.3) 78.2 (72.9–80.0) 76.9 (73.0–81.9) 80.4 (73.0–83.4) 78.0 (73.7–83.7)
Data shown as median (IQR).
GM-CSF, granulocyte macrophage colony-stimulating factor; PAF, platelet-activating factor.
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initially to be released from the lung more rapidly than acutely
PAF primed cells, although this was not statistically signiﬁcant,
raising the possibility that for a single priming agent, pulmonary
neutrophil retention may scale with the priming intensity (n=6).
The dataset is summarised in ﬁgure 2C. The 40 min peripheral
blood recovery of neutrophils exposed to PAF for 30 min was
27.6% (26.4–31.4%) compared with values for unprimed cells
of 37.3% (33.1–39.9%).
ARDS is associated with a failure of neutrophil depriming
and increased systemic levels of neutrophil priming
Our data demonstrating the ability of the pulmonary vasculature
to retain primed neutrophils and release them back into the cir-
culation at a later point led us to the hypothesis that the pul-
monary vasculature may play an important role in host defence,
Table 3 Demographic data of transpulmonary gradient study
patients
Group
Age
(years) Sex
P/F ratio
(kPa) Diagnosis
Perioperative
controls
62 Male 78.2 Oesophagectomy for
malignancy
29 Male 81.0 Oesophagectomy for
non-malignant constriction
70 Female 74.8 Oesophagectomy malignancy
70 Male 82.7 Oesophagectomy for
malignancy
48 Male 88.1 Oesophagectomy malignancy
Sepsis 48 Female 40.0 Chronic liver disease
84 Male 44.4 Gram-negative bacteraemia
70 Female 44 Streptococcal bacteraemia
66 Female 48.2 Biliary sepsis
55 Female 42.8 Large bowel perforation
79 Female 53.7 Small bowel perforation
ARDS 29 Female 13.3 H1N1 influenza
39 Male 23.3 Polytrauma
79 Male 14.9 Septic shock of unknown
source
75 Male 13.0 Community acquired
pneumonia
48 Female 14.0 Chronic liver disease
84 Male 13.7 Necrotising fasciitis
51 Male 15.7 Hospital-acquired pneumonia
71 Male 17 Biliary sepsis
ARDS, acute respiratory distress syndrome.
Table 2 Demographics of subjects undergoing outflow tract
sampling
Surgical
procedure
Age
(years) Sex
Cardiac
output
(L/min)
Peripheral blood
neutrophil count
(109/L)
Radical cystectomy 69 Male 5.5 2.9
Radical cystectomy 80 Male 3.1 5.0
Radical cystectomy 76 Male 5.9 7.6
Radical cystectomy 65 Female 5.7 4.4
Oesophagectomy 53 Male 5.7 5.5
Oesophagectomy 75 Male 5.2 2.6
All pulmonary transit measurements were undertaken with subjects supine, receiving
6 ml/kg predicted body weight tidal volume ventilation, positive end-expiratory
pressure of 5 cm H2O and FiO2 0.5.
Figure 2 Effect of neutrophil priming on pulmonary transit kinetics.
Autologous 99mtechnetium-labelled neutrophils were primed with
granulocyte macrophage colony-stimulating factor (100 ng/mL, 30 min,
n=8), platelet-activating factor (1 μM, 5 min, n=5; or 30 min, n=6) or
control (phosphate-buffered saline, 5 min, n=8), washed twice with
autologous plasma (150 g, 5 min) and resuspended in plasma, before
being reinjected into the left antecubital fossa of healthy spontaneously
breathing volunteers, lying supine in a dual-headed γ camera. Images
were acquired at 1/s for 2 min, followed by 1/20 s for 38 min, from the
time of injection. Regions of interest were drawn around the lungs and
the average count per pixel recorded. The data were corrected for
radioisotope decay and plotted against time. A γ variate was ﬁtted to
the control data to simulate a ﬁrst-pass transit curve for unprimed
neutrophils (A), from which a mean transit time of 14.18 s (14.06–
14.61 s) was derived. (C) Shows the median and IQR of data obtained
from all 27 independent experiments. *Represents p<0.05 compared
with control. To validate our ﬁndings regarding the transit kinetics of
unprimed neutrophils, autologous 99mtechnetium-labelled erythrocytes
and 111indium-labelled neutrophils were mixed with lithium chloride
and injected as a single bolus into the right internal jugular veins of
patients with healthy lungs (normal spirometry and thoracic CT) under
surgical anaesthesia. Starting immediately prior to injection, continuous
blood sampling was undertaken from the left radial artery (collected in
3.6 s fractions) using a peristaltic pump and fraction collector. Blood
99mtechnetium and 111indium activity was measured, with appropriate
corrections for background, crosstalk and radionuclide decay, and
expressed as a fraction of the administered activities. Each ﬁrst-pass
curve was ﬁtted with a γ variate function to calculate the area under
the ﬁrst-pass curve and the difference in lung mean transit times of
erythrocytes and neutrophils. (B) Shows the median and IQR of six
independent patient studies.
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protecting the systemic circulation from the histotoxic effects of
primed neutrophils by trapping and depriming neutrophils, and
further, that should this mechanism fail, neutrophilic pulmonary
inﬂammation, such as that seen in ARDS, may result.
To test this hypothesis, simultaneous paired blood samples
were taken from the internal jugular vein and radial artery of
patients with sepsis, ARDS and perioperative controls. We used
assays speciﬁcally designed to evaluate neutrophil number and
priming status in whole blood to avoid further ex vivo changes.
Primed neutrophils were considered to be shape changed (as
assessed by mean forward scatter), CD11bhigh/CD62Llow, whilst
unprimed neutrophils were non-shape changed and CD11blow/
CD62Lhigh.
We detected no signiﬁcant gradient across the lungs with
respect to absolute neutrophil count, neutrophil shape change,
or neutrophil CD11b expression in any of our subject groups
(ﬁgure 3A–C). However, a signiﬁcant difference in the transpul-
monary gradient of CD62L expression was observed (ﬁgure 3D;
p<0.05). There was no difference between the transpulmonary
gradient of CD62L expression of patients with sepsis and
control subjects, suggesting that in these subjects the capacity to
deprime neutrophils was intact. In contrast, subjects with ARDS
had a signiﬁcant decrease in transpulmonary gradient of CD62L
expression compared with controls (p<0.05), indicating that
the lung’s capacity to retain and deprime neutrophils may have
been compromised. Of interest, the transpulmonary gradient of
CD62L expression correlated with the oxygenation status of
patients with ARDS (R=0.7857, p<0.05; ﬁgure 4).
Online supplementary ﬁgure S1 shows the changes in the
transpulmonary gradient of CD62L occurring in a patient with
sepsis who subsequently developed ARDS.
DISCUSSION
ARDS affects 200 000 people per annum in the USA and this
ﬁgure is set to increase over the next 25 years.2 A substantial
Figure 3 Measurement of neutrophil priming gradients across the lungs. Paired samples of whole blood were obtained from the radial artery and
internal jugular veins of critically ill patients with systemic sepsis (n=6), acute respiratory distress syndrome (ARDS) (n=8), or perioperative controls
(n=5). Absolute neutrophil count was measured using a Coulter DXH. Neutrophil shape change and cell surface expressions of CD11b and CD62L
were measured using no lysis whole blood ﬂow cytometry. Gradients were expressed as the ratio of the arterial value over the venous value.
(A) Shows a scatter plot (with mean and IQR) for neutrophil count, (B) shape change (expressed as mean forward scatter), (C) shows CD11b cell
surface expression, and (D) shows CD62L cell surface expression. Analysed using Kruskal–Wallis test with Dunn’s post hoc comparisons.
*Represents p<0.05.
Figure 4 Correlation between A and V gradient of neutrophil CD62L
cell surface expression and oxygenation status in patients with acute
respiratory distress syndrome (ARDS). Paired samples of whole blood
were obtained from the radial artery and internal jugular veins of
patients with ARDS (n=8 patients). Neutrophil cell surface expression of
CD62L was measured using no lysis whole blood ﬂow cytometry.
Gradients were expressed as the ratio of the arterial value over the
venous value. The P/F ratio (pO2 in arterial blood/fraction of inspired
oxygen) was recorded at the time each sample was taken. Figure 4
shows the Spearman correlation between A and V gradient of
neutrophil CD62L cell surface expression and P/F ratio (R=0.7857,
p<0.05).
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proportion of these patients die as a result of multiorgan failure.
The mechanism linking ARDS, a disease characterised by pul-
monary inﬂammation and severe hypoxeamic respiratory
failure, to extra-pulmonary organ dysfunction is uncertain,
however, clinical and experimental studies support the concept
of organ crosstalk.
Neutrophils are key cells in the pathogenesis of ARDS. Clinical
studies have shown that neutrophil accumulation within the pul-
monary vasculature occurs early in the evolution of ARDS,19 and
neutrophilic alveolitis is a histological hallmark.20 Neutrophilia is
common in the bronchoalveolar lavage ﬂuid of patients with
ARDS21 and the extent of this correlates with clinical outcome.22
Animal models also support the importance of neutrophils in
ARDS: neutrophil depletion ameliorates the extent of ARDS,23–
27 and delayed neutrophil apoptosis, or failure of apoptotic cell
clearance, is associated with worsened inﬂammation and
increased mortality.28 However, the presence of neutrophils per
se is not necessarily damaging, with the priming/activation status
of these cells being the major determinant of their subsequent
injury limiting/inducing behaviour.29 30
Using ex vivo primed autologous human neutrophils and γ
scintigraphy, we have shown that neutrophil priming can mark-
edly prolong pulmonary transit time in a manner that is priming
agent speciﬁc. We have also shown that the vast majority of neu-
trophils, isolated and labelled under conditions that cause
minimal activation, pass through the pulmonary circulation with
minimal delay. The accumulation of deliberately primed neutro-
phils within the pulmonary vasculature was reversible and did
not result in cell migration into the pulmonary interstitium. Our
data suggest that the healthy human pulmonary vasculature may
play a role in host defence, protecting the systemic circulation
from the toxic effects of primed neutrophils by retaining
primed neutrophils and later re-releasing them back into the sys-
temic circulation in a deprimed state. Further, we observed that
ARDS was associated with a signiﬁcantly decreased transpul-
monary gradient of CD62L expression, suggesting that a failure
of neutrophil depriming may occur in patients with ARDS,
resulting in the presence of elevated levels of primed neutrophils
within the systemic circulation. The presence of elevated levels
of primed neutrophils within the systemic circulation provides a
plausible crosstalk mechanism for the extra-pulmonary organ
damage observed in patients with ARDS. Additionally, the
increased concentrations of circulating cytokines often found in
patients with ARDS may cooperate with the circulating primed
neutrophils to inﬂict extra-pulmonary organ damage. An alter-
native explanation for the ﬁnding of the elevated level of circu-
lating primed neutrophils observed in subjects with ARDS is
that the lung itself had become a source of neutrophil priming.
The transpulmonary gradient of CD62L expression was corre-
lated with the oxygenation status of patients with ARDS.
The ‘catch and release’ of primed neutrophils by the pulmon-
ary vasculature is entirely consistent with previous studies in
which intravenously injected lipopolysaccharide and/or
N-formyl-neoleucyl-leucyl-phenylalanine (FNLP) caused the
accumulation of 111indium-labelled neutrophils in the lungs of
rabbits.31 32 In these experiments the accumulation of primed
neutrophils in the lung was also reversible. Our current data are
also consistent with a previous study in humans in which PAF
inhalation was shown to induce a temporary blood neutropenia
associated with increased lung accumulation of 111indium-
labelled neutrophils.33 While intravenous lipopolysaccharide
and FNLP models the effects of systemic sepsis and the inhaled
PAF study explores more the effect of pulmonary inﬂammation
on previously native neutrophils, the ﬁndings of temporary neu-
trophil sequestration within the pulmonary vasculature is con-
sistent and supports our current work.
Our ﬁndings have several limitations. This work used neutro-
phils primed ex vivo and infused into healthy subjects. It is pos-
sible that the data obtained may not reﬂect the true in vivo
situation in an individual with acute inﬂammation, as theoretic-
ally there may be substantial differences between ex vivo and in
vivo primed neutrophils; however, we know of no data to
support this suggestion. We were not able to quantify the mean
pulmonary transit times of primed neutrophils on ﬁrst pass
because their marked retention prevented any attempt to math-
ematically model the ﬁrst-pass transit, which relies on some
degree of loss of signal following the initial peak. However, as
there was very minimal decrease in the lung signal over the ﬁrst
2 min following injection of either PAF or GM-CSF primed
cells, the absolute transit time for these cells is likely to be con-
siderably longer than 2 min compared with our observed transit
time of 14.18 s for unprimed neutrophils. The subjects studied
in the coinjection experiments were mainly undergoing surgery
for abdominal malignancy; whilst none had smoked in the pre-
ceding 6 months, and all had normal chest radiographs and lung
function, they cannot be considered entirely healthy subjects,
unlike the volunteers recruited for the γ scintigraphy studies.
The current data suggesting a very rapid transit of unprimed
neutrophils across the lung does not preclude the possibility of a
small subpopulation (<5%) of more slowly transiting cells that
are not evident beneath the signal generated by the predomin-
antly fast transiting cells. Measuring the transit time of such a
population of neutrophils during in vivo human studies is
extremely challenging, as it necessitates prevention of any recir-
culation. All that can be concluded based on the observed reten-
tion fraction and the mono-exponential nature of the
pulmonary washout curves is that >95% of neutrophils are not
delayed within the lung on ﬁrst pass. In contrast to our experi-
ments, many earlier studies examining neutrophil transit across
the lung demonstrating higher pulmonary retention values were
conducted in animals which have been shown to have neutro-
phils that are less deformable than human neutrophils, and a
larger fraction of pulmonary capillaries with a diameter less
than that of neutrophils.34 Further, recovery values based on
tritium-labelled cells have also been shown to vary between
species.35 The majority of earlier studies undertook radiolabel-
ling with indium oxide, which requires the separation of the
neutrophils from autologous plasma, thus altering their subse-
quent in vivo transit kinetics.12
In conclusion, we provide evidence that the healthy human
pulmonary vasculature may play a role in host defence by retain-
ing primed neutrophils and later releasing them back into the
systemic circulation in a deprimed state. We have also shown
that ARDS is associated with elevated levels of primed neutro-
phils within the systemic circulation, suggesting that ARDS may
be associated with a failure of neutrophil depriming, thus pro-
viding a potential ‘crosstalk’ mechanism for the remote organ
damage that is the predominant cause of mortality and long-
term morbidity in patients with ARDS.
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